Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 30.93 USD -2.15% Market Closed
Market Cap: 3.8B USD
Have any thoughts about
Guardant Health Inc?
Write Note

Guardant Health Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guardant Health Inc
Cost of Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Guardant Health Inc
NASDAQ:GH
Cost of Revenue
-$274.7m
CAGR 3-Years
-33%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.5B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.4B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$316.5B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$206.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$9.2B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is Guardant Health Inc's Cost of Revenue?
Cost of Revenue
-274.7m USD

Based on the financial report for Sep 30, 2024, Guardant Health Inc's Cost of Revenue amounts to -274.7m USD.

What is Guardant Health Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-34%

Over the last year, the Cost of Revenue growth was -30%. The average annual Cost of Revenue growth rates for Guardant Health Inc have been -33% over the past three years , -34% over the past five years .

Back to Top